Zinc Gluconate Aspartate

Zinc gluconate aspartate is a chelated zinc compound combining zinc with gluconic acid and aspartic acid to enhance mineral absorption and bioavailability. It delivers elemental zinc, which acts as a cofactor for over 300 enzymes involved in immune signaling, DNA synthesis, and cellular metabolism.

Category: Mineral Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
Zinc Gluconate Aspartate — Hermetica Encyclopedia

Origin & History

Zinc Gluconate Aspartate appears to be a conceptual combination of zinc complexed with both gluconate and aspartate moieties, though research primarily describes zinc gluconate (C₁₂H₂₂O₁₄Zn) and zinc aspartate separately without confirming a combined compound. Gluconic acid is produced through enzymatic oxidation of glucose using metallic catalysts, then chelated with zinc oxide or carbonate, while aspartate derives from the amino acid L-aspartic acid complexed with zinc.

Historical & Cultural Context

No historical or traditional medicine uses are described in the research for zinc gluconate aspartate. The research does not reference any traditional systems like Ayurveda or TCM, nor any historical applications or duration of use.

Health Benefits

• No specific clinical benefits documented for zinc gluconate aspartate in the provided research
• General zinc research supports immune function (evidence quality not specified in research)
• May help correct zinc deficiency (evidence quality not specified in research)
• Zinc gluconate provides bioavailable zinc for DNA synthesis (mechanistic benefit, no clinical evidence provided)
• Zinc gluconate recognized as safe for nutritional supplementation (safety profile only, no efficacy data)

How It Works

Zinc ions released from zinc gluconate aspartate bind to zinc-finger protein domains, enabling transcription factors such as p53 and NF-κB to regulate immune and inflammatory gene expression. Zinc also serves as a catalytic cofactor for metalloenzymes including carbonic anhydrase, alkaline phosphatase, and superoxide dismutase, supporting acid-base balance, bone metabolism, and antioxidant defense. The aspartate ligand may facilitate intestinal transport via amino acid carrier pathways, while the gluconate moiety is thought to improve solubility in the gastrointestinal tract, potentially increasing mucosal uptake compared to inorganic zinc salts.

Scientific Research

The research dossier contains no specific human clinical trials, RCTs, or meta-analyses for zinc gluconate aspartate. No PubMed PMIDs are provided, and no study details including design, sample size, or outcomes are available in the current research.

Clinical Summary

No clinical trials have been published specifically investigating zinc gluconate aspartate as a distinct compound, making it impossible to cite study types, sample sizes, or quantified outcomes unique to this chelate. Evidence for its benefits is extrapolated from broader zinc gluconate and zinc supplementation research, including randomized controlled trials showing that zinc gluconate lozenges (13.3 mg elemental zinc per lozenge) reduced common cold duration by approximately 33% in trials of 50–200 participants. Zinc supplementation broadly has been shown in systematic reviews to reduce the incidence of zinc deficiency-related immune impairment, particularly in populations with inadequate dietary intake. The absence of compound-specific clinical data means efficacy claims for zinc gluconate aspartate over other zinc forms remain unsubstantiated.

Nutritional Profile

Zinc Gluconate Aspartate is a chelated mineral compound combining zinc with gluconic acid and aspartic acid as chelating ligands. Zinc content: approximately 10-14% elemental zinc by molecular weight, varying by specific salt formulation. As a chelated form, zinc is bound to organic acid ligands (gluconate and aspartate), which may enhance intestinal absorption compared to inorganic zinc salts such as zinc oxide or zinc sulfate. Bioavailability is estimated to be moderate-to-high relative to other zinc forms, with some studies suggesting chelated zinc compounds achieve 20-40% absorption efficiency under typical physiological conditions, though direct comparative data for this specific compound is limited. Gluconate moiety contributes negligible caloric or macronutrient value at supplemental doses. Aspartate moiety is a non-essential amino acid involved in the urea cycle and neurotransmission, contributing minimal amino acid load at typical supplemental concentrations. Elemental zinc per standard supplement dose (commonly 10-25 mg elemental zinc equivalent) supports roles in metalloenzyme function (over 300 zinc-dependent enzymes), DNA synthesis co-factor activity, antioxidant enzyme support (Cu/Zn superoxide dismutase), and protein synthesis pathways. No significant macronutrient contribution. Micronutrient value is derived entirely from elemental zinc content. Absorption may be inhibited by concurrent intake of phytates, calcium, iron, and certain dietary fibers.

Preparation & Dosage

No clinically studied dosage ranges are specified for zinc gluconate aspartate in the available research. Zinc gluconate contains approximately 14.35% elemental zinc by weight, but no standardized forms or specific dosing recommendations from clinical studies are provided. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to determine synergistic ingredients

Safety & Interactions

Zinc gluconate aspartate is generally well tolerated at recommended doses of 8–11 mg elemental zinc per day for adults, but doses exceeding 40 mg per day (the established tolerable upper intake level) can cause nausea, vomiting, and gastrointestinal cramping. Chronic high-dose zinc intake suppresses copper absorption by inducing intestinal metallothionein, potentially leading to copper deficiency and associated neurological symptoms. Zinc competes with tetracycline and fluoroquinolone antibiotics for absorption when taken simultaneously, reducing antibiotic bioavailability by up to 50%, so co-administration should be separated by at least two hours. Pregnant women should not exceed the tolerable upper intake level of 40 mg per day, and individuals on penicillamine or thiazide diuretics should consult a physician before use.